disagree...i think it has just tested long term resistance and failed.will see low 20's imodyro!regards,
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025